» Articles » PMID: 24101363

Long-term Trends in Incidence, Survival and Mortality of Primary Penile Cancer in England

Overview
Specialties Oncology
Public Health
Date 2013 Oct 9
PMID 24101363
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Few population-based studies exist of long-term trends in penile cancer. We report incidence and mortality trends in England over the 31 years 1979-2009 and survival trends over the 40 years 1971-2010.

Methods: We calculated annual incidence and mortality rates per 100,000 by age and calendar period. We estimated incidence and mortality rate ratios for cohorts born since 1890, and one- and five-year relative survival (%) by age and deprivation category.

Results: A total of 9,690 men were diagnosed with penile cancer during 1979-2009. Age-standardized incidence rates increased by 21 %, from 1.10 to 1.33 per 100,000. Mortality rates fell by 20 % after 1994, from 0.39 to 0.31 per 100,000. Survival analyses included 11,478 men diagnosed during 1971-2010. Five-year relative survival increased from 61.4 to 70.2 %. Five-year survival for men diagnosed 2006-2010 was 77 % for men aged under 60 years and 53 % for men aged 80-99 years. The 8 % difference in five-year survival (66-74 %) between men in the most affluent and most deprived groups was not statistically significant.

Conclusions: The 21 % increase in penile cancer incidence in England since the 1970s may be explained by changes in sexual practice, greater exposure to sexually transmitted oncogenic human papilloma viruses, and decreasing rates of childhood circumcision. Improvement in survival is likely due to advances in diagnostic, staging and surgical techniques. There is a need for public health education and potential preventative strategies to address the increasing incidence.

Citing Articles

Body mass index and penile cancer incidence: results from a Norwegian cohort study of 829,081 men.

Aune D, Nordsletten M, Myklebust T, Robsahm T, Skalhegg B, Mala T BMC Urol. 2024; 24(1):260.

PMID: 39605013 PMC: 11603744. DOI: 10.1186/s12894-024-01636-z.


Epidemiology of penile cancer in Poland compared to other European countries.

Wnetrzak I, Czajkowski M, Baranska K, Miklewska M, Wojciechowska U, Sosnowski R Cancer Med. 2024; 13(16):e70092.

PMID: 39164960 PMC: 11335812. DOI: 10.1002/cam4.70092.


Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination.

Malagon T, Franco E, Tejada R, Vaccarella S Nat Rev Clin Oncol. 2024; 21(7):522-538.

PMID: 38760499 DOI: 10.1038/s41571-024-00904-z.


A study protocol for a feasibility randomised controlled trial investigating videoendoscopic radical inguinal lymphadenectomy versus open radical inguinal lymphadenectomy in patients with penile cancer (VELRAD).

Tang S, Akers C, Alnajjar H, Ayres B, Baldini C, Embleton-Thirsk A Pilot Feasibility Stud. 2024; 10(1):61.

PMID: 38600541 PMC: 11005199. DOI: 10.1186/s40814-024-01474-8.


Long-term outcomes of penile squamous cell carcinoma in men age ≤50 years old compared with men >50 years old from a single tertiary referral centre: a propensity score matched analysis.

Pang K, Fallara G, Hemat M, Ghosh A, Haider A, Freeman A Int J Impot Res. 2024; .

PMID: 38424353 DOI: 10.1038/s41443-024-00842-5.